Figure S1: Effects of in utero arsenic exposure on (A) maternal weight gains during gestation (represented as ratio between weight at birth and weight at the beginning of treatment; control n=7; 10 ppb n=7; 42.5 ppm n=7); (B) numbers of pups per litter (Control n=7; 10 ppb n=7; 42.5 ppm n=7) and (C) body weights of fetuses at E18 (Control n=46; 10 ppb n=30; 42.5 ppm n=38). All bars indicate mean ± SE and * indicates P< 0.05 compared to control. 
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Supplemental Figure S2
Figure S2: Effects of in utero arsenic exposure on the ovarian morphology (H&E stained; bar represents 100 um) at 21 days, 28 days and 6 months of age. C. D.
